Stifel Financial’s AbbVie ABBV Stock Holding History

Stifel Financial’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-600	Closed	-$36K	–	2301
2014 Q4	$36K	Hold	600	–	–	﹤0.01%	2233
2014 Q3	$38K	Buy	600 +200	+50%	+$11.1K	﹤0.01%	2162
2014 Q2	$21K	Buy	+400	New	+$21K	﹤0.01%	2175

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Stifel Financial's ABBV Position: Q2 2026 in Review

Stifel Financial reduced its AbbVie (ABBV) stake by 2.9% in Q2 2026, selling an estimated $23M and leaving 3,625,155 shares worth $912M. The position accounts for 0.76% of the portfolio, ranked #18.

Stifel Financial first reported a position in ABBV in Q1 2014 and has held it in 50 quarters since. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Stifel Financial held 3,625,155 shares of AbbVie worth $912M as of Q2 2026.
Stifel Financial sold 107,049 AbbVie shares in Q2 2026, an estimated $23M.
AbbVie made up 0.76% of Stifel Financial's portfolio in Q2 2026, its #18 holding.
Stifel Financial first reported a position in AbbVie in Q1 2014 and has held it in 50 quarters since.
4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.